Extracorporeal membrane oxygenation can support adult, pediatric, infant and neonatal
patients.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in AnesthesiaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome: single-centre experience with 1-year follow-up.Eur J Cardiothorac Surg. 2012; 41: 691-695
- Studies in extracorporeal circulation. II. A method for the recovery and use of blood from the open heart during extracorporeal circulation in man.Ann Surg. 1956; 144: 223-227
- A personalized history of extracorporeal circulation.Trans Am Soc Artif Intern Organs. 1982; 28: 5-16
- Extracorporeal circulation for support of palliative cardiac surgery in infants.Ann Thorac Surg. 1970; 10: 354-363
- Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy.Trans Am Soc Artif Intern Organs. 1976; 22: 80-93
- A perfusion system for infants.Trans Am Soc Artif Intern Organs. 1969; 15: 155-160
- Evaluation of a disposable plastic, low volume, pumpless oxygenator as a lung substitute.J Pediatr. 1965; 66: 94-102
Extracorporeal Life Support Organization. General Guidelines for all ECLS Cases. 2017. Available at: https://www.elso.org/Portals/0/ELSO%20Guidelines%20General%20All%20ECLS%20Version%201_4.pdf. Accessed October 1, 2017.
- Low blood flow extracorporeal carbon dioxide removal (ECCO2R): a review of the concept and a case report.Intensive Care Med. 1995; 21: 594-597
- An expanded definition of the adult respiratory distress syndrome.Am Rev Respir Dis. 1988; 138: 720-723
- Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study.JAMA. 1979; 242: 2193-2196
- Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure.JAMA. 1986; 256: 881-886
- Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome.Am J Respir Crit Care Med. 1994; 149: 295-305
- Increased survival of ARDS patients with severe hypoxemia (ECMO criteria).Chest. 1991; 99: 951-955
- Extracorporeal life support as a bridge to lung transplantation.Clin Chest Med. 2011; 32: 245-251
- Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome.JAMA. 2009; 302: 1888-1895
- Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.Lancet. 2009; 374: 1351-1363
- Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis.Lancet. 2008; 372: 554-561
- Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock.Crit Care Med. 2008; 36: 1404-1411
- Duration of cardiopulmonary resuscitation before extracorporeal rescue: how long is not long enough?.ASAIO J. 2005; 51: 665-667
- Back from irreversibility: extracorporeal life support for prolonged cardiac arrest.Ann Thorac Surg. 2005; 79 ([discussion: 183–4]): 178-183
- The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device.Ann Thorac Surg. 2001; 71 ([discussion: S82–5]): S77-S81
- Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest: a comparison with conventional cardiopulmonary resuscitation.Crit Care Med. 2011; 39: 1-7
- Postcardiotomy mechanical support: risk factors and outcomes.Ann Thorac Surg. 2001; 71 ([discussion: S82–5]): S60-S66
- Extracorporeal resuscitation of cardiac arrest.Acad Emerg Med. 1999; 6: 700-707
- Adult extracorporeal membrane oxygenation: an international survey of transfusion and anticoagulation techniques.Vox Sang. 2017; 112: 443-452
- Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass.Acta Anaesthesiol Scand. 2004; 48: 697-703
- Extracorporeal life support registry report 2004.ASAIO J. 2005; 51: 4-10
- Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation.Ann Thorac Surg. 2004; 77: 612-618
- Successful management of a case of massive air embolism from cardiopulmonary bypass with retrograde cerebral perfusion in a child.J Cardiothorac Vasc Anesth. 2006; 20: 80-81
- Hyperbaric oxygenation for arterial air embolism during cardiopulmonary bypass.Ann Thorac Surg. 1993; 55: 401-403
- Morbidity for survivors of extracorporeal membrane oxygenation: neurodevelopmental outcome at 1 year of age.Pediatrics. 1989; 83: 72-78
- Intracranial abnormalities in infants treated with extracorporeal membrane oxygenation: update on sonographic and CT findings.AJNR Am J Neuroradiol. 1996; 17: 287-294
- Use of extracorporeal membrane oxygenation in the septic neonate.J Pediatr Surg. 1995; 30: 813-815
- Cerebral outcome in adult patients treated with extracorporeal membrane oxygenation.Ann Thorac Surg. 2006; 81: 1401-1406
- Neurological injury in adults treated with extracorporeal membrane oxygenation.Arch Neurol. 2011; 68: 1543-1549
- Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation.Eur J Cardiothorac Surg. 1999; 15: 508-514
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.Crit Care. 2007; 11: R31
- Prognosis in the patients with prolonged extracorporeal membrane oxygenation.Korean J Thorac Cardiovasc Surg. 2012; 45: 236-241
- Renal function and survival in 200 patients undergoing ECMO therapy.Nephrol Dial Transplant. 2013; 28: 86-90
- Predictors of mortality in patients successfully weaned from extracorporeal membrane oxygenation.PLoS One. 2012; 7: e42687
- Limb ischemia after common femoral artery cannulation for venoarterial extracorporeal membrane oxygenation: an unresolved problem.J Pediatr Surg. 2010; 45: 2136-2140
- Peripheral versus central cannulation for extracorporeal membrane oxygenation: a comparison of limb ischemia and transfusion requirements.Thorac Cardiovasc Surg. 2010; 58: 459-462
- Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support.Ann Thorac Surg. 2011; 92: 626-631
- Cerebral and lower limb near-infrared spectroscopy in adults on extracorporeal membrane oxygenation.Artif Organs. 2012; 36: 659-667
- Defining risk for infectious complications on extracorporeal life support.J Pediatr Surg. 2011; 46: 2260-2264
- Infections occurring during extracorporeal membrane oxygenation use in adult patients.J Thorac Cardiovasc Surg. 2010; 140: 1125-1132 e2
- The independent association of massive blood loss with mortality in cardiac surgery.Transfusion. 2004; 44: 1453-1462
Argatroban injection for intravenous injection. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022485lbl.pdf. Accessed October 1, 2017.
Fresenius Kabi USA L. Heparin sodium injection. Prescribing information. 2016. Available at: https://www.fresenius-kabi.com/en-ca/documents/Heparin-PI-ENG-v1.2-Clean.pdf. Accessed October 1, 2017.
Talecris Biotherapeutics. Antithrombin III (human) Thrombate. Prescribing information. 2016. Available at: http://www.thrombate.com/documents/975812/975869/ThrombateIII_PI_3036431_Aug_2013.pdf/9337c369-130e-4e8b-98ea-1f5220fb0f34. Accessed October 1, 2017.
TM Company. Angiomax (bivalirudin) for injection. Prescribing information. 2016. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020873s036lbl.pdf. Accessed October 1, 2017.
- Massive systemic air embolism during extracorporeal membrane oxygenation support of a neonate with acute respiratory distress syndrome after cardiac surgery.J Extra Corpor Technol. 2011; 43: 86-88
- Venovenous extracorporeal membrane oxygenation in adults: practical aspects of circuits, cannulae, and procedures.J Cardiothorac Vasc Anesth. 2012; 26: 893-909
- Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit.Br J Haematol. 1996; 94: 517-525
- Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs.Arterioscler Thromb Vasc Biol. 2003; 23: 1690-1696
- Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the Corline heparin surface.Scand Cardiovasc J. 2002; 36: 351-357
- The presence and release of tissue factor from human platelets.Platelets. 2002; 13: 247-253
- Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa.J Thromb Haemost. 2012; 10: 1355-1362
- Hemolysis during long-term extracorporeal membrane oxygenation.J Pediatr. 1989; 115: 625-630
- Enhanced hemolysis in pediatric patients requiring extracorporeal membrane oxygenation and continuous renal replacement therapy.Ann Thorac Cardiovasc Surg. 2007; 13: 378-383
- Erythrocyte damage and destruction induced by shearing stress.J Lab Clin Med. 1968; 71: 784-790
- Shear-induced fragmentation of human erythrocytes.Biorheology. 1973; 10: 303-311
- Comparison of pressure-volume-flow relationships in centrifugal and roller pump extracorporeal membrane oxygenation systems for neonates.ASAIO Trans. 1991; 37: 572-576
- Bypass circuits as the source of thromboemboli during extracorporeal membrane oxygenation.J Pediatr. 1989; 115: 621-624
- The effects of subatmospheric pressure on the haemolysis of blood.J Biomech. 1975; 8: 321-325
- Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure.Am J Physiol. 1989; 256: F446-F455
- The natural history of direct hyperbilirubinemia associated with extracorporeal membrane oxygenation.Am J Dis Child. 1992; 146: 1176-1180
- Carboxyhemoglobin formation as an unexpected side effect of inhaled nitric oxide therapy in severe acute respiratory distress syndrome.Crit Care Med. 2004; 32: 2537-2539
- Microembolic signals and strategy to prevent gas embolism during extracorporeal membrane oxygenation.J Cardiothorac Surg. 2010; 5: 5
- High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation.Intensive Care Med. 1997; 23: 819-835
- Anticoagulation and coagulation management for ECMO.Semin Cardiothorac Vasc Anesth. 2009; 13: 154-175
- Blood activation during neonatal extracorporeal life support.J Thorac Cardiovasc Surg. 1993; 105: 823-832
- Effect of extracorporeal membrane oxygenation on platelets in newborns.Crit Care Med. 1993; 21: 1029-1034
- The significant relationship between platelet count and haemorrhagic complications on ECMO.Perfusion. 1994; 9: 265-269
- Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model.Br J Anaesth. 2009; 102: 793-799
- Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients.Heart Lung Circ. 2008; 17: S41-S47
- P-selectin induces the expression of tissue factor on monocytes.Proc Natl Acad Sci U S A. 1994; 91: 8767-8771
- The protein C pathway.Chest. 2003; 124: 26S-32S
- The impact of the inflammatory response on coagulation.Thromb Res. 2004; 114: 321-327
- Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense.Microcirculation. 2003; 10: 335-350
- The dynamics of thrombin formation.Arterioscler Thromb Vasc Biol. 2003; 23: 17-25
- Antithrombin replacement during extracorporeal membrane oxygenation.Artif Organs. 2011; 35: 1024-1028
- Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants.J Pediatr. 1996; 129: 264-268
- A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass.Anesthesiology. 2005; 102: 276-284
- Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.J Thorac Cardiovasc Surg. 2005; 130: 107-113
- Inactivation of heparin during extracorporeal-circulation in infants.Clin Pharmacol Ther. 1990; 48: 148-154
- Whole-blood activated clotting time in infants during extracorporeal membrane-oxygenation.Crit Care Med. 1990; 18: 494-498
- Evaluation of heparin assay for coagulation management in newborns undergoing ECMO.Am J Clin Pathol. 2010; 134: 950-954
- Prophylaxis of venous thrombosis following total hip and total knee replacement using antithrombin III and heparin.Semin Hematol. 1991; 28: 39-45
- Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation.Ann Thorac Surg. 1994; 58 ([discussion: 804–5]): 799-804
- Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig.Eur J Cardiothorac Surg. 1991; 5: 486-491
- Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.J Thorac Cardiovasc Surg. 1992; 103: 806-813
- Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.J Thorac Cardiovasc Surg. 1992; 104: 642-647
- Findings with recording ellipsometer suggesting rapid exchange of specific plasma proteins at liquid/solid interfaces.Surf Sci. 1969; 16: 438
- The Vroman effect: competitive protein exchange with dynamic multilayer protein aggregates.Colloids Surf B Biointerfaces. 2013; 103: 395-404
- The protein C anticoagulant pathway.Arterioscler Thromb. 1992; 12: 135-145
- Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis.J Trauma. 2008; 64 ([discussion: 1217]): 1211-1217
- Coagulation and anticoagulation in extracorporeal membrane oxygenation.Artif Organs. 1999; 23: 979-983
- A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO.J Pediatr Surg. 1998; 33: 1610-1613
- The treatment of classical hemophilia with cryoprecipitates. Laboratory control with readily available tests.JAMA. 1966; 198: 243-247
- Activated coagulation time of whole blood.JAMA. 1966; 196: 436-440
- Activated coagulation time as screening test.JAMA. 1972; 222: 583-584
- Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.Thromb Haemost. 1997; 77: 270-277
- Anticoagulation and pediatric extracorporeal membrane oxygenation: Impact of activated clotting time and heparin dose on survival.Ann Thorac Surg. 2007; 83: 912-920
- The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery.J Cardiothorac Vasc Anesth. 1996; 10: 458-463
- North American neonatal extracorporeal membrane oxygenation (ECMO) devices: 2002 survey results.J Extra Corpor Technol. 2004; 36: 16-21
- Maintaining adequate anticoagulation on extracorporeal membrane oxygenation therapy: Hemochron Junior Low Range versus Hemochron 400.J Extra Corpor Technol. 2003; 35: 35-38
- Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.J Thorac Cardiovasc Surg. 1994; 108: 1076-1082
- Bedside monitoring of heparin therapy: comparison of activated clotting time to activated partial thromboplastin time.Cathet Cardiovasc Diagn. 1994; 32: 49-52
- Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation.ASAIO J. 2007; 53: 111-114
- A comparison of five devices for the bedside monitoring of heparin therapy.Anaesth Intensive Care. 1991; 19: 592-596
- Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.Pediatr Crit Care Med. 2014; 15: e72-e79
- C-reactive protein, fibrinogen, and cardiovascular disease prediction.N Engl J Med. 2012; 367: 1310-1320
- Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study.Thromb Haemost. 1993; 70: 380-385
- Use of a novel anticoagulation strategy during ECMO in a pediatric population: single-center experience.ASAIO J. 2006; 52: 513-516
- Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices.Anesth Analg. 2008; 106: 1366-1375
- Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO).Int J Artif Organs. 2006; 29: 1121-1131
- Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation.Perfusion. 2013; 28: 54-60
- Blood transfusion requirements and independent predictors of increased transfusion requirements among adult patients on extracorporeal membrane oxygenation – a single centre experience.Vox Sang. 2009; 96: 34-43
- Predictors of increased transfusion requirements and optimizing transfusional support in patients on extracorporeal membrane oxygenation (ECMO).ISBT Sci Ser. 2012; 7: 89-91
- Blood utilization in adult patients undergoing extracorporeal membrane oxygenated therapy.Transfusion. 1996; 36: 61-63
- Safety of recombinant activated factor VII in randomized clinical trials.N Engl J Med. 2010; 363: 1791-1800
- Fatal thrombosis after factor VII administration during extracorporeal membrane oxygenation.J Cardiothorac Vasc Anesth. 2008; 22: 259-260
- Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII.J Thorac Cardiovasc Surg. 2002; 124: 852-854
Article info
Identification
Copyright
© 2017 Elsevier Inc. All rights reserved.
